A TRIAL COMPARING INSULIN DEGLUDEC/LIRAGLUTIDE AND INSULIN DEGLUDEC IN COMBINATION WITH METFORMIN IN CHINESE SUBJECTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH BASAL INSULIN THERAPY AND METFORMIN WITH OR WITHOUT ONE OTHER ORAL ANTIDIABETIC DRUG (OAD):